POSTER SESSION III Tuesday, March 4, 2008   —  9:30 AM - 12:00 Noon Convention Center Exhibit Hall A Click on the blue numbers in parentheses to display abstracts. Click the button next to any title to add to Itinerary Planner... BREAST PATHOLOGY Poster# Title and Authors Itinerary Planner 40 Comparison of Estrogen Receptor and Progesterone Receptor Assay Results from Pathology Reports with Results from Centralized Testing: Implications for Population-Based Studies (195) J Marotti, R Tamimi, H Baer, J Connolly, G Colditz, S Schnitt, L Collins - Beth Israel Deaconess Medical Center, Boston, MA; Harvard Medical School, Boston, MA; Harvard School of Public Health, Boston, MA; Brigham and Women's Hospital, Boston, MA; Alvin J. Siteman Cancer Center and Washington University School of Medicine, St. Louis, MO Add 41 Dual Expression of a-Tocopherol Associated Protein and ER in Normal Human Breast Epithelium and Its Down Regulation in ER Positive Carcinomas (170) S Johnykutty, P Tang, SY Yeh, X Wang - University of Rochester Medical School, Rochester, NY Add 42 Novel Non Biotin Polymeric Immunodetection Systems Provide Stronger Signal without Background in Estrogen Receptor Evaluation of Breast Carcinomas (227) RM Rocha, NG Moraes, J Vassallo, F Soares, H Gobbi - UFMG, Belo Horizonte, Brazil; UNICAMP, Campinas, Brazil; Hospital do Cancer, Sao Paulo, Brazil Add 43 Is ER/HER2 Testing Indicated in All Histologic Types of Breast Cancer? (226) C Reyes, M Nassiri, M Nadji - University of Miami/Jackson Memorial Hospital, Miami, FL Add 44 Comparison of ER and PR Assessment by Local IHC, Central IHC, and Central Quantitative RT-PCR in ECOG Breast Cancer Study 2197 ¤78¥ S Badve, FL Baehner, R Gray, B Childs, T Maddala, M Liu, S Rowley, N Davidson, y, LJ Goldstein, GW Sledge, JA Sparano - Indiana University, Indianapolis, IN; Genomic Health, Redwood City, CA; Eastern Cooperative Oncology Group, Brookline, MA; Sanofi-Aventis, Bridgewater, NJ; Sidney Kimmel Cancer Center, Baltimore, MD; Montefiore-Einstein Cancer Center, Bronx, NY Add 45 Analysis of Fixative Type (Formalin vs Penfix) and Fixation Time for Hormone Receptors and Her 2 Immunohistochemical: A Validation Study (231) CR Rund, RD Klemens, DJ Dabbs - University of Pittsburgh, Pittsburgh, PA Add 46 HER2, Estrogen Receptor and Progesterone Receptor Status in Primary Breast Carcinomas and Paired Axillary Lymph Node Metastases (116) MM Desouki, DJ Wolff, J Geradts, SE Self - Medical University of SC, Charleston, SC; Duke University, Durham, NC Add 47 A Kaiser-Permanente Population-Based Study of Breast Cancer ER and PR Expression by the Standard Method, Immunohistochemistry, Compared to a New Method, Quantitative Reverse Transcription Polymerase Chain Reaction (81) FL Baehner, T Maddala, C Alexander, A Gown, LC Goldstein, y, S Shak, CP Quesenberry, L Habel - University of California, San Francisco, San Francisco, CA; Genomic Health, Redwood City, CA; PhenoPath, Seattle, WA; Kaiser Permanente, Oakland, CA Add 48 The Novel Estrogen-Induced Gene EIG121 Is Over-Expressed in ER-Positive Breast Cancers and Promotes Autophagy (101) RR Broaddus, L Deng - M.D. Anderson Cancer Center, Houston, TX Add 49 Novel Rabbit Monoclonal Antibody SP3 Demonstrates Excellent Concordance with Flourescence In-Situ Hybridization in 262 Invasive Breast Carcinomas and Is a Reliable Antibody To Assess HER-2/neu Status (108) YB Chen, A Cimino, T Rengifo, V Najfeld, SJ Shin - Weill Cornell Medical College, New York, NY; Mount Sinai Hospital, New York, NY Add 50 Heterogeneity of Quantitative RT-PCR Measurement of Estrogen and Progresterone Receptor Expression: Comparison of Tissue Microarray Cores to Whole Sections of Paraffin Embedded Breast Cancer Tissue (83) FL Baehner, J Baker, J Salter, ML Liu, C Yoshizawa, T Maddala, M Dowsett, M Cronin, S Shak - University of California, San Francisco, SF, CA; Genomic Health, Inc, Redwood City, CA; Royal Marsden Hospital, London, United Kingdom Add 51 A Prospective Study Comparing SP1 and 1D5 Monoclonal Antibodies to the Estrogen Receptor Reveals Similar Staining Results in Routine Clinical Use (102) JE Brock, JL Hornick, A Richardson, D Dillon, SC Lester - Brigham & Women's Hospital, Boston Add 52 Bone Metastasis Is Strongly Associated ER Positive/PR Negative Breast Carcinomas (249) P Tang, J Wang, P Bourne, H Bu, B Wei - University of Rochester Medical Center, Rochester, NY, United Kingdom; RTI Health Solution, Research Triangle Park, NC; Huaxi Hospital of Sichuan University, Chengdu, Sichuan, China Add 53 Invasive Solid Papillary Carcinoma of the Breast: A Clinicopathologic Analysis of 52 Cases (248) F Tang, MZ Gilcrease, CT Albarracin, L Huo, LP Middleton, E Resetkova, Y Wu - Huashang Hospital, Fudan University, Shanghai, China; University of Texas M.D. Anderson Cancer Center, Houston, TX Add 54 Mucinous Variant of Micropapillary Breast Carcinoma: An Aggressive Neoplasm That Needs To Be Distinguished from a Low-Grade Mucinous (Colloid) Carcinoma (88) V Barbashina, C Vallejo, LK Tan, E Brogi - Memorial Sloan-Kettering Cancer Center, New York, NY Add 55 Papillary Lesions Diagnosed by Core Needle Biopsy of the Breast: Diagnostic Pitfalls and Management Update (241) TB Sheridan, WA Berg, JK Warner, OB Ioffe - Univ of MD, Baltimore, MD; Johns Hopkins Green Spring, Lutherville, MD Add 56 CK8/18 Expression Profiles and the Diagnostic Utility of a CK5/p63/CK8/18 Antibody Cocktail in the Evaluation of Papillary Lesions of the Breast (86) NN Balmer, AL Adams, O Hameed - University of Alabama School of Medicine, Birmingham, AL Add 57 Peritumoral Lymphatic Microvessel Density and Lymphovascular Invasion Detected by D2-40 as Prognostic Markers in Invasive Micropapillary Breast Carcinoma (232) RS Saad, C Rowsell, YL El-Gohary, WH Hanna - Sunnybrook Health Science Center, Toronto, ON, Canada Add 58 Matrix-Producing Carcinoma of the Breast: Clinicopathologic Features Associated with Locoregional Recurrence and Survival (120) E Downs-Kelly, KM Nayeemuddin, C Albarracin, Y Wu, KK Hunt, MZ Gilcrease - M.D. Anderson Cancer Center, Houston, TX Add 59 Myoepithelial Carcinoma of the Breast: A Clinicopathological and Immunohisytochemical Study of 11 Cases (96) V Bossuyt, N Zekry, F Tavassoli - Yale School of Medicine, New Haven, CT Add 60 Comparison of the Clinicopathologic Features and Prognosis of Epithelial and Mixed Metaplastic Carcinomas of the Breast (131) AC Gavino, Y Peng - University of Texas Southwestern Medical Center, Dallas, TX Add